Detalhe da pesquisa
1.
Basal biomarkers nestin and INPP4B predict gemcitabine benefit in metastatic breast cancer: Samples from the phase III SBG0102 clinical trial.
Int J Cancer
; 144(10): 2578-2586, 2019 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30411790
2.
Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-up.
Breast Cancer Res Treat
; 168(1): 107-115, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29159761
3.
Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor.
Histopathology
; 70(2): 185-194, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402148
4.
A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard.
Mod Pathol
; 26(11): 1438-50, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23702728
5.
Variable performance of commercial epidermal growth factor receptor antibodies in detection of basal-like breast cancer.
Histopathology
; 61(3): 518-9, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22642766
6.
Quantitative Detection and Resolution of BRAF V600 Status in Colorectal Cancer Using Droplet Digital PCR and a Novel Wild-Type Negative Assay.
J Mol Diagn
; 18(2): 190-204, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26762843